Microchip Technology Incorporated
MCHPP NASDAQTechnology ★★★★★Latest Earnings FY2026 Q3 Above forecast↑
Date
Nov 5, 2026
ET
EPS Est.
0.94
EPS Actual
0.97
Revenue Est.
$1.61B
Revenue Actual
$1.62B
Next Earnings Report Date unconfirmed
Date
Feb 4, 2027 · Thu
ET Feb 4, 2027 · Thu
Time
2/4 21:00-2/5 01:00
After-market(ET)
Fiscal Period
FY2026 Q4
EPS Est.
0.91
Revenue Est.
$1.61B
Company Overview
Microchip Technology Incorporated (ticker MCHPP) is listed on NASDAQ with a market cap of about $28.26B. Its next earnings report (FY2026 Q4) is expected on Feb 4, 2027 (ET), After-market (date pending company confirmation), with consensus EPS of 0.91. In the last 9 reported quarters, EPS beat consensus estimates 8 times.
Actual EPS TrendRecently9Term · Nov 5, 2024 → FY2026 Q3
Nov 5, 2024Range: 0.11 ~ 0.97FY2026 Q3
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Nov 5, 2026 | FY2026 Q3 | 0.94 | Above forecast↑0.97 | $1.61B | $1.62B |
| Oct 29, 2026 | -- | 0.94 | -- | $1.61B | -- |
| Aug 6, 2026 | -- | 0.70 | Above forecast↑0.76 | $1.46B | $1.48B |
| May 7, 2026 | -- | 0.51 | Above forecast↑0.57 | $1.26B | $1.31B |
| Feb 5, 2026 | -- | 0.43 | Above forecast↑0.44 | $1.18B | $1.19B |
| Nov 6, 2025 | -- | 0.34 | Above forecast↑0.35 | $1.14B | $1.14B |
| Aug 7, 2025 | -- | 0.24 | Above forecast↑0.27 | $1.06B | $1.08B |
| May 8, 2025 | -- | 0.10 | Above forecast↑0.11 | $962.6M | $970.5M |
| Feb 6, 2025 | -- | 0.28 | Below forecast↓0.20 | $1.05B | $1.03B |
| Nov 5, 2024 | -- | 0.43 | Above forecast↑0.46 | $1.15B | $1.16B |
Original Filings (SEC)
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
